📣 Webinar alert! Join Primal Pictures 3D Anatomy & Physiology / Anatomy.tv on September 3rd or 5th for "Optimizing Anatomy and Physiology Learning: A Unified Digital Approach for Students, Librarians & Faculty." Two sessions, sign up today: https://ow.ly/Nysq50T9Yav.
About us
Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health care professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory-related decisions and create real-world opportunities for growth. Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more.
- Website
-
https://www.citeline.com/
External link for Citeline
- Industry
- Information Services
- Company size
- 501-1,000 employees
- Headquarters
- New York, New York
- Type
- Privately Held
Locations
-
Primary
New York, New York, US
-
London, City of London, GB
Employees at Citeline
Updates
-
⏰ Webinar alert: last day to register! 📆 Register now: https://ow.ly/y42W50SUIsk. Join us on September 5th to gain an understanding of the roles and responsibilities of EU and UK Qualified Persons (QPs) and the impact of recent regulatory updates on the supply chain. Experts from Thermo Fisher Scientific will delve into the critical functions of EU and UK QPs, the QP oversight process for UK imports, special considerations for cold or frozen advanced therapy medicinal products, and strategies for effective QP collaboration. Don't miss this opportunity to enhance your knowledge and network with industry professionals. Register today!
-
-
📣New Series Alert: Medtech on the Brain 🧠 Read more about the promise of the Neuronetics, Inc.'s NeuroStar transcranial magnetic stimulation system: https://ow.ly/B4BB50T3xSM. Medtech Insight is highlighting awareness for mental health, Alzheimer’s and brain health by speaking with industry leaders about rising innovations to address neurological diseases and mental health, the regulatory and investment climate, reimbursement, and more. Check out the entire series here: https://ow.ly/5awS50T3xSL.
-
🌟 News. Context. Impact: your weekly premium content roundup. Click "see more" to read individual articles. Check back next week for more! From Generics Bulletin—Xbrane Reveals Urgency To Find A Partner For One Of Two Biosimilars By October: https://ow.ly/olGa50TcNev. From In Vivo—2025’s Therapy Area Growth Drivers And Brakes: Part One – The Top Three By Revenues: https://ow.ly/OEu650TcNeE. From HBW Insight—‘Inside Regulatory Affairs’ With AESGP’s Christelle Anquez-Traxler and Oliver Hartmann: https://ow.ly/wCCy50TcNey.
-
Citeline reposted this
Cell and gene therapies (C>s) experienced a landmark close to 2023 and maintained momentum into Q1 2024. https://lnkd.in/gJcBNkA9 According to the latest quarterly Gene, Cell & RNA Therapy Landscape Report by Citeline in association with the American Society of Gene & Cell Therapy (ASCGT), this period saw several notable approvals and strong growth across all stages of clinical development. Click the link in this post to learn more about the current evolution of cell therapy. #Pipeline2Patient #FollowNorstella
-
Citeline reposted this
Citeline's Therapy Area Director Pamela Spicer is featured in a Pharmacy Times “Pharmacy Focus” podcast focusing on the current pipeline of Alzheimer’s drugs and what the future holds for these therapeutics: https://ow.ly/91Bs50T9pvL. She leads off the discussion, speaking about the difference in patients included in Aduhelm studies as compared to those for Leqembi, why Biogen decided to reprioritize different treatments.
-
-
📆 Last chance to register! https://ow.ly/rixj50TcNec. Citeline's Lya Rebelo will be part of a roundtable discussion on the FDA's revised guidance for diversity in clinical trials and how it will impact both sponsors and sites. #FDA #DiversityActionPlans #ClinicalTrialDiversity #DiversityInResearch #FDARegulations #InclusiveTrials #ClinicalTrialInclusion
-
-
📣 Webinar alert! Join Primal Pictures 3D Anatomy & Physiology / Anatomy.tv on September 3rd or 5th for "Optimizing Anatomy and Physiology Learning: A Unified Digital Approach for Students, Librarians & Faculty." Two sessions, sign up today: https://ow.ly/hQ1150T9Y9w.
-
-
⚠️ Last call for entries to the 29th OTC Marketing Awards! This is your final chance to compete in categories like Best OTC Public Relations Campaign, Best OTC Audiovisual Advertising, and OTC Launch of the Year. Gain the prestige of winning 'the Oscars of the industry' - but you must act fast, as entries close this Friday. https://ow.ly/1ars50SG4s1 #OTCMarketingAwards
-
-
Citeline reposted this
The results are in! In a recent poll, we asked and you responded. Here’s what our audience had to say about what would inspire them to participate in clinical research. View our carousel for all the details. https://lnkd.in/gB4zbHKN #clinicaltrials #clinicaltrial #clinicalresearch